Effect of Intracameral Phenylephrine/Ketorolac on Intraoperative Pain

Effect of Intracameral Phenylephrine/Ketorolac on Intraoperative Pain

To compare the effect of intraoperative intracameral Omidria (Phenylephrine and Ketorolac 1.0%/0.3%) verses 1% Lidocaine on pain reduction during and after cataract surgery.

Inclusion Criteria:

• Individuals with a cataract in the surgical eye

Exclusion Criteria:

• Patients that have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivative, and other nonsteroidal anti-inflammatory drugs (NSAIDs)
• Those with a past medical history of asthma
• Those systemically using opioids or nonsteroidal anti-inflammatory drugs
• Those prescribed additional topical mydriatics, topical steroids, pilocarpine, or prostaglandins in the week preceding surgery
• Those with a history of alpha-1-adrenergic antagonist use
• Those with excisional, intraocular surgery in the planned surgical eye in the preceding year
• Those with a history of iris damage
• Those requiring iris expanding device or those with an acute or chronic uncontrolled eye condition, or those unable to effectively remember surgery or complete the post-operative assessment.
• Additionally, individuals less than 21 will be excluded.